The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 30, 2024

Filed:

Jul. 28, 2017
Applicant:

Som Innovation Biotech, S.l., Barcelona, ES;

Inventors:

Anna Nardi Ricart, Barcelona, ES;

Josep María Suñé Negre, Barcelona, ES;

Núria Reig Bolaño, Barcelona, ES;

Raúl Insa Boronat, Barcelona, ES;

Oscar Huertas Gambín, Barcelona, ES;

Santiago Esteva Gras, Barcelona, ES;

Gal⋅Ia Pericot Mohr, Barcelona, ES;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/20 (2006.01); A61K 31/122 (2006.01); A61K 31/12 (2006.01);
U.S. Cl.
CPC ...
A61K 9/2054 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2095 (2013.01); A61K 31/12 (2013.01); A61K 31/122 (2013.01);
Abstract

The present invention relates to sustained release tablet comprising micronized tolcapone, a release retardant and a binder, to said tablet for use in the prevention and/or treatment of a transthyretin-associated amyloidosis, to a method for the prevention and/or treatment of a transthyretin-associated amyloidosis comprising administering to a subject in need thereof an effective amount of said tablet, to pharmaceutical composition in the form of said tablet which is used in the prevention and/or treatment of a transthyretin-associated amyloidosis and to a process for the manufacture of said tablet.


Find Patent Forward Citations

Loading…